Drugs / SIR-Spheres
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00766220 Comparator | Oct 2009 → Jan 2012 | colon carcinoma | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SIR-Spheres | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00766220 ↗ |
| Modality | Other / unclassified | “SIR-Spheres, resin microspheres containing pure Beta emitter Yttrium-90” NCT00766220 ↗ |
| Route | Other | “given through femoral catheter over 10 minutes” NCT00766220 ↗ |